Morgan Stanley’s Franklin Genomic Advancements ETF HELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43 Hold
1
﹤0.01% 7834
2025
Q1
$33 Buy
+1
New +$33 ﹤0.01% 7848